{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:20:00Z","timestamp":1787599200625,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04549-5","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:25:58Z","timestamp":1787595958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intraoperative radiotherapy vs. multicatheter brachytherapy as accelerated partial-breast irradiation: a secondary analysis of two multicenter prospective cohorts"],"prefix":"10.1007","author":[{"given":"Laura","family":"Garc\u00eda-Cabrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Pinar-Sede\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Rodriguez-Ibarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Auxiliadora","family":"Cabez\u00f3n-Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Lopez-Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Rey-Baltar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Rodr\u00edguez-Melc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lloret-Saez-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1709-6232","authenticated-orcid":false,"given":"Pedro C.","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"4549_CR1","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists Collaborative Group (EBCTCG) (2011). Effects of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomized trials.\u00a0Lancet\u00a0378: 1707\u20131716","DOI":"10.1016\/S0140-6736(11)61629-2"},{"key":"4549_CR2","doi-asserted-by":"crossref","unstructured":"START Trialists\u2019 Group; Bentzen, S.M.; Agrawal, R.K.; Aird, E.G.; Barrett, J.M.; Barrett-Lee, P.J.; Dobbs, H.J.; Hopwood, P.; Lawton, P.A.; Magee, B.J.; et al (2008). The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial.\u00a0Lancet Oncol.\u00a09: 331\u2013341.","DOI":"10.1016\/S1470-2045(08)70077-9"},{"key":"4549_CR3","doi-asserted-by":"crossref","unstructured":"START Trialists\u2019 Group; Bentzen, S.M.; Agrawal, R.K.; Aird, E.G.; Barrett, J.M.; Barrett-Lee, P.J.; Bentzen, S.M.; Bliss, J.M.; Brown, J.; Dewar, J.A.; et al (2008). The UK Standardization of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomized trial.\u00a0Lancet\u00a0371: 1098\u20131107.","DOI":"10.1016\/S0140-6736(08)60348-7"},{"key":"4549_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513\u201320.","journal-title":"N Engl J Med"},{"key":"4549_CR5","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"AM Brunt","year":"2020","unstructured":"Brunt AM, Haviland JS, Wheatley AD, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicenter, non-inferiority, randomized, phase 3 trial. Lancet. 2020;395:1613\u201326.","journal-title":"Lancet"},{"key":"4549_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0140-6736(05)60950-6","volume":"349","author":"M Baum","year":"1997","unstructured":"Baum M, Vaidya JS, Mittra I. Multicentricity and recurrence of breast cancer. Lancet. 1997;349:208.","journal-title":"Lancet"},{"key":"4549_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.radonc.2010.07.011","volume":"100","author":"S Lettmaier","year":"2011","unstructured":"Lettmaier S, Kreppner S, Lotter M, Walser M, Ott OJ, Fietkau R, et al. Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: a dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy. Radiother Oncol. 2011;100:189\u201394.","journal-title":"Radiother Oncol"},{"key":"4549_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","volume":"51","author":"L Livi","year":"2015","unstructured":"Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451\u201363.","journal-title":"Eur J Cancer"},{"key":"4549_CR9","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","volume":"390","author":"CE Coles","year":"2017","unstructured":"Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, et al. Partial-breast radiotherapy after breast conservation surgery for patients withearly breast cancer (UK IMPORT-LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet. 2017;390:1048\u201360.","journal-title":"Lancet"},{"key":"4549_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","volume":"387","author":"V Strnad","year":"2016","unstructured":"Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;387:229\u201338.","journal-title":"Lancet"},{"key":"4549_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.prro.2023.11.001","volume":"14","author":"SF Shaitelman","year":"2024","unstructured":"Shaitelman SF, Anderson BM, Arthur DW, Bazan JG, Bellon JR, Bradfield L, et al. Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline. Pract Radiat Oncol. 2024;14:112\u201332.","journal-title":"Pract Radiat Oncol"},{"key":"4549_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.radonc.2018.04.009","volume":"128","author":"V Strnad","year":"2018","unstructured":"Strnad V, Major T, Polgar C, Lotter M, Guinot JL, Gutierrez-Miguelez C, et al. ESTRO-ACROP guideline: interstitial multi-catheter breast brachytherapy as accelerated partial breast irradiation alone or as boost\u2014GEC-ESTRO breast cancer working group practical recommendations. Radiother Oncol. 2018;128:411\u201320.","journal-title":"Radiother Oncol"},{"issue":"3","key":"4549_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.radonc.2010.01.014","volume":"94","author":"C Polg\u00e1r","year":"2010","unstructured":"Polg\u00e1r C, Van Limbergen E, P\u00f6tter R, Kov\u00e1cs G, Polo A, Lyczek J, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europ\u00e9en de Curieth\u00e9rapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010;94(3):264\u201373. https:\/\/doi.org\/10.1016\/j.radonc.2010.01.014.","journal-title":"Radiother Oncol"},{"key":"4549_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2010.01.019","volume":"94","author":"C Polgar","year":"2010","unstructured":"Polgar C, Major T, Fodor J, Sulyok Z, Somogyi A, L\u00f6vey K, et al. Accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol. 2010;94:274\u20139.","journal-title":"Radiother Oncol"},{"key":"4549_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijrobp.2010.01.020","volume":"80","author":"V Strnad","year":"2011","unstructured":"Strnad V, Hildebrandt G, Potter R, Hammer J, Hindemith M, Resch A, et al. Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2011;80:17\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4549_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.prro.2023.03.006","volume":"13","author":"C Yashar","year":"2023","unstructured":"Yashar C, Khan AJ, Chen P, Einck J, Poppe M, Li L, et al. Three-fraction accelerated partial breast irradiation (APBI) delivered with interstitial brachytherapy is safe: first results from the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) trial. Pract Radiat Oncol. 2023;13:314\u201320.","journal-title":"Pract Radiat Oncol"},{"key":"4549_CR17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ijrobp.2020.11.006","volume":"109","author":"C Polg\u00e1r","year":"2021","unstructured":"Polg\u00e1r C, Major T, Tak\u00e1csi-Nagy Z, Fodor J. Breast-conserving surgery followed by partial or whole breast irradiation: twenty-year results of a phase 3 clinical study. Int J Radiat Oncol Biol Phys. 2021;109:998\u20131006.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4549_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1470-2045(23)00018-9","volume":"24","author":"V Strnad","year":"2023","unstructured":"Strnad V, Polg\u00e1r C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, et al. Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial. Lancet Oncol. 2023;24:262\u201372.","journal-title":"Lancet Oncol"},{"key":"4549_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1470-2045(17)30011-6","volume":"18","author":"C Polg\u00e1r","year":"2017","unstructured":"Polg\u00e1r C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18:259\u201368.","journal-title":"Lancet Oncol"},{"key":"4549_CR20","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(18)30195-5","volume":"19","author":"R Sch\u00e4fer","year":"2018","unstructured":"Sch\u00e4fer R, Strnad V, Polg\u00e1r C, Uter W, Hildebrandt G, Ott OJ, et al. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast- conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. Lancet Oncol. 2018;19:834\u201344.","journal-title":"Lancet Oncol"},{"key":"4549_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.breast.2020.04.008","volume":"52","author":"NG Rodriguez-Ibarria","year":"2020","unstructured":"Rodriguez-Ibarria NG, Pinar MB, Garc\u00eda L, Cabez\u00f3n MA, Lloret M, Rey-Baltar MD, et al. Accelerated partial breast irradiation with interstitial multicatheter brachytherapy after breast-conserving surgery for low-risk early breast cancer. Breast. 2020;52:45\u20139.","journal-title":"Breast"},{"key":"4549_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16061138","volume":"16","author":"NG Rodr\u00edguez-Ibarria","year":"2024","unstructured":"Rodr\u00edguez-Ibarria NG, Pinar B, Garc\u00eda L, Cabez\u00f3n A, Rey-Baltar D, Rodr\u00edguez-Melc\u00f3n JI, et al. Ten-year results of accelerated partial-breast irradiation with interstitial multicatheter brachytherapy after breast-conserving surgery for low-risk early breast cancer. Cancers. 2024;16:1138. https:\/\/doi.org\/10.3390\/cancers16061138.","journal-title":"Cancers"},{"key":"4549_CR23","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","volume":"14","author":"U Veronesi","year":"2013","unstructured":"Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013;14:1269\u201377.","journal-title":"Lancet Oncol"},{"key":"4549_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","volume":"383","author":"JS Vaidya","year":"2014","unstructured":"Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383:603\u201313.","journal-title":"Lancet"},{"key":"4549_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.radonc.2020.04.059","volume":"149","author":"G Fastner","year":"2020","unstructured":"Fastner G, Gaisberger C, Kaiser J, Scherer P, Ciabattoni A, Petoukhova A, et al. ESTRO IORT task force\/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer. Radiother Oncol. 2020;149:150\u20137.","journal-title":"Radiother Oncol"},{"key":"4549_CR26","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/S0140-6736(14)60825-4","volume":"383","author":"J Cuzick","year":"2014","unstructured":"Cuzick J. Radiotherapy for breast cancer, the TARGIT-A trial. Lancet. 2014;383:1716.","journal-title":"Lancet"},{"key":"4549_CR27","doi-asserted-by":"publisher","first-page":"e200249","DOI":"10.1001\/jamaoncol.2020.0249","volume":"6","author":"JS Vaidya","year":"2020","unstructured":"Vaidya JS, Bulsara M, Saunders C, Flyger H, Tobias JS, Corica T, et al. Effect of delayed targeted intraoperative radiotherapy vs. whole-breast radiotherapy on local recurrence and survival: long-term results from the TARGIT-A randomized clinical trial in early breast cancer. JAMA Oncol. 2020;6:e200249.","journal-title":"JAMA Oncol"},{"key":"4549_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2836","volume":"370","author":"JS Vaidya","year":"2020","unstructured":"Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S, et al. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGITA randomised clinical trial. BMJ. 2020;370:m2836.","journal-title":"BMJ"},{"key":"4549_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17111762","volume":"17","author":"L Garc\u00eda-Cabrera","year":"2025","unstructured":"Garc\u00eda-Cabrera L, Pinar-Sede\u00f1o B, Cabez\u00f3n-Pons MA, Rodriguez-Ibarria N, Dominguez-Dominguez A, Aguiar-Santana D, et al. Long-term results of a prospective multicenter trial of APBI with photon IORT. Cancers. 2025;17:1762.","journal-title":"Cancers"},{"key":"4549_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-023-07112-w","volume":"203","author":"LV Ravani","year":"2024","unstructured":"Ravani LV, Calomeni P, Wang M, Deng D, Speers C, Zaorsky NG, et al. Comparison of partial-breast irradiation and intraoperative radiation to whole-breast irradiation in early-stage breast cancer patients: a Kaplan-Meier-derived patient data meta-analysis. Breast Cancer Res Treat. 2024;203:1\u201312.","journal-title":"Breast Cancer Res Treat"},{"key":"4549_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.brachy.2020.03.003","volume":"19","author":"GA Viani","year":"2020","unstructured":"Viani GA, Arruda CV, Faustino AC, De Fendi LI. Partial-breast irradiation versus whole-breast radiotherapy for early breast cancer: a systematic review and update meta-analysis. Brachytherapy. 2020;19:491\u20138.","journal-title":"Brachytherapy"},{"key":"4549_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.786515","volume":"12","author":"JS Vaidya","year":"2022","unstructured":"Vaidya JS, Vaidya UJ, Baum M, Bulsara MK, Joseph D, Tobias JS. Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer-better for patients, better for healthcare systems. Front Oncol. 2022;12:786515.","journal-title":"Front Oncol"},{"key":"4549_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000515386","volume":"17","author":"MD Piroth","year":"2022","unstructured":"Piroth MD, Strnad V, Krug D, Fastner G, Baumann R, Combs SE, et al. Long-term results of the TARGIT-A trial: more questions than answers. Breast Care (Basel). 2022;17:81\u20134.","journal-title":"Breast Care (Basel)"},{"key":"4549_CR34","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s12094-022-02823-w","volume":"24","author":"M Laplana","year":"2022","unstructured":"Laplana M, Garc\u00eda-Marqueta M, S\u00e1nchez-Fern\u00e1ndez JJ, Mart\u00ednez-P\u00e9rez E, P\u00e9rez-Montero H, Mart\u00ednez-Montesinos I, et al. Effectiveness and safety of intraoperative radiotherapy (IORT) with low-energy X-rays (INTRABEAM) for accelerated partial breast irradiation (APBI). Clin Transl Oncol. 2022;24:1732\u201343.","journal-title":"Clin Transl Oncol"},{"key":"4549_CR35","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1111\/tbj.13827","volume":"26","author":"A Tallet","year":"2020","unstructured":"Tallet A, Racadot S, Boher JM, Cohen M, Barrou J, Houvenaeghel G, et al. The actual benefit of intraoperative radiation therapy using 50 kV x-rays in early breast cancer: a retrospective study of 676 patients. Breast J. 2020;26:2145\u201350.","journal-title":"Breast J"},{"key":"4549_CR36","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1245\/s10434-020-09432-3","volume":"28","author":"SA Valente","year":"2021","unstructured":"Valente SA, Tendulkar RD, Cherian S, Shah C, Ross DL, Lottich SC, et al. TARGIT-R (retrospective): 5-year follow-up evaluation of intraoperative radiation therapy (IORT) for breast cancer performed in North America. Ann Surg Oncol. 2021;28:2512\u201321.","journal-title":"Ann Surg Oncol"},{"key":"4549_CR37","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.clbc.2021.05.002","volume":"22","author":"SO Guillerm","year":"2022","unstructured":"Guillerm SO, Bourstyn E, Itti R, Cahen-Doidy L, Qu\u00e9ro L, Labidi M, et al. Intraoperative radiotherapy for breast cancer in elderly women. Clin Breast Cancer. 2022;22:e109\u201313.","journal-title":"Clin Breast Cancer"},{"key":"4549_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1424630","volume":"14","author":"L Vinante","year":"2024","unstructured":"Vinante L, Vaidya JS, Caroli A, Mileto M, Piccoli E, Avanzo M, et al. Real world clinical outcomes from targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer: data from a large cohort at a national cancer institute. Front Oncol. 2024;14:1424630.","journal-title":"Front Oncol"},{"key":"4549_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2207586","volume":"388","author":"IH Kunkler","year":"2023","unstructured":"Kunkler IH, Williams LJ, Jack WJL, Cameron DA, Dixon JM. Breast-conserving surgery with or without irradiation in early breast cancer. N Engl J Med. 2023;388:585\u201394.","journal-title":"N Engl J Med"},{"key":"4549_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000041632","volume":"104","author":"AM Taha","year":"2025","unstructured":"Taha AM, Kamel HA, Khlidj Y, Salem DS, Saed SAA, Abouelmagd K, et al. Adjuvant radiotherapy in postmenopausal women with early-stage ER-positive breast cancer: a systematic review and meta-analysis. Medicine. 2025;104:e41632.","journal-title":"Medicine"},{"key":"4549_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174343","volume":"15","author":"J Haussmann","year":"2023","unstructured":"Haussmann J, Budach W, Corradini S, Krug D, B\u00f6lke E, Tamaskovics B, et al. Whole breast irradiation in comparison to endocrine therapy in early stage breast cancer-a direct and network meta-analysis of published randomized trials. Cancers. 2023;15:4343.","journal-title":"Cancers"},{"key":"4549_CR42","doi-asserted-by":"crossref","unstructured":"Hannoun-Levi, J.M.; Chamorey, E.; Boulahssass, R.; Polgar, C.; Strnad, V (2021) .Breast Cancer Working Group of the GEC-ESTRO. Endocrine therapy with accelerated partial breast irradiation or exclusive ultra-accelerated partial breast irradiation for women aged >60 years with early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial.\u00a0Clin. Transl. Radiat. Oncol.\u00a029: 1\u20138.","DOI":"10.1016\/j.ctro.2021.04.005"},{"key":"4549_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1470-2045(24)00661-2","volume":"26","author":"I Meattini","year":"2025","unstructured":"Meattini I, De Santis MC, Visani L, Scorsetti M, Fozza A, Meduri B, et al. Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial. Lancet Oncol. 2025;26:37\u201350.","journal-title":"Lancet Oncol"},{"key":"4549_CR44","doi-asserted-by":"publisher","unstructured":"Polg\u00e1r C, Gutierrez-Miguelez C, Ivanov O, Smanyk\u00f3 V, Stankiewicz M, Mart\u00ednez I, L\u00f6ssl K, Guinot JL, Major T, Hannoun-Levi JM, Strnad V (2026) GEC-ESTRO Breast Cancer Working Group. Patient selection for accelerated partial breast irradiation (APBI) after breast-conserving surgery: Updated evidence-based recommendations of the Groupe Europ\u00e9en de Curieth\u00e9rapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) Breast Cancer Working Group. Clin Transl Radiat Oncol. 59:101170. https:\/\/doi.org\/10.1016\/j.ctro.2026.101170. PMID: 42058323; PMCID: PMC13122701","DOI":"10.1016\/j.ctro.2026.101170"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04549-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:26:00Z","timestamp":1787595960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04549-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":44,"alternative-id":["4549"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04549-5","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Dr. Negr\u00edn University Hospital (protocol code 2019\u2013490-1; 28 November 2019).","order":3,"name":"Ethics","label":"IRB approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}